Invesco Ltd. Tekla Life Sciences Investors Transaction History

Invesco Ltd.

$453 Billion
Q1 2024

A detailed history of Invesco Ltd. transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Invesco Ltd. holds 21,044 shares of HQL stock, worth $280,306. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,044

Holding current value

$280,306

% of portfolio

0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$13.38 - $14.33 $281,568 - $301,560	21,044 New	21,044 $286,000
Q3 2023 Nov 13, 2023	SELL	$12.38 - $13.69 $19,993 - $22,109	-1,615 Reduced 11.32%	12,652 $157,000
Q2 2023 Aug 11, 2023	SELL	$13.13 - $14.17 $538 - $580	-41 Reduced 0.29%	14,267 $193,000
Q1 2023 May 12, 2023	SELL	$13.37 - $14.94 $181,203 - $202,481	-13,553 Reduced 48.65%	14,308 $199,000
Q4 2022 Feb 13, 2023	SELL	$13.55 - $15.23 $199,361 - $224,078	-14,713 Reduced 34.56%	27,861 $395,000

Q3 2022 Nov 14, 2022	SELL	$13.39 - $16.31 $25,092 - $30,564	-1,874 Reduced 4.22%	42,574 $582,000
Q2 2022 Aug 15, 2022	SELL	$13.11 - $17.02 $452,635 - $587,632	-34,526 Reduced 43.72%	44,448 $632,000
Q1 2022 May 16, 2022	SELL	$15.35 - $19.29 $215,728 - $271,101	-14,054 Reduced 15.11%	78,974 $1.31 Million
Q4 2021 Feb 14, 2022	BUY	$18.5 - $21.59 $118,418 - $138,197	6,401 Added 7.39%	93,028 $1.79 Million
Q3 2021 Nov 15, 2021	SELL	$20.27 - $22.67 $343,738 - $384,437	-16,958 Reduced 16.37%	86,627 $1.8 Million
Q2 2021 Aug 17, 2021	SELL	$19.14 - $21.44 $84,847 - $95,043	-4,433 Reduced 4.1%	103,585 $2.22 Million
Q1 2021 May 17, 2021	BUY	$19.31 - $22.07 $448,976 - $513,149	23,251 Added 27.43%	108,018 $2.13 Million
Q4 2020 Feb 16, 2021	BUY	$16.8 - $20.21 $140,212 - $168,672	8,346 Added 10.92%	84,767 $1.67 Million
Q3 2020 Nov 16, 2020	BUY	$16.71 - $19.06 $276,918 - $315,862	16,572 Added 27.69%	76,421 $1.34 Million
Q2 2020 Aug 14, 2020	BUY	$14.22 - $18.38 $43,698 - $56,481	3,073 Added 5.41%	59,849 $1.08 Million
Q1 2020 May 15, 2020	SELL	$12.22 - $17.99 $17,938 - $26,409	-1,468 Reduced 2.52%	56,776 $851,000
Q4 2019 Feb 14, 2020	SELL	$14.63 - $17.84 $654,356 - $797,929	-44,727 Reduced 43.44%	58,244 $1.02 Million
Q3 2019 Nov 14, 2019	SELL	$15.09 - $17.09 $498,694 - $564,790	-33,048 Reduced 24.3%	102,971 $1.56 Million
Q2 2019 Aug 14, 2019	SELL	$15.54 - $17.47 $231,530 - $260,285	-14,899 Reduced 9.87%	136,019 $2.29 Million
Q1 2019 May 15, 2019	SELL	$15.5 - $17.9 $514,925 - $594,655	-33,221 Reduced 18.04%	150,918 $2.59 Million
Q4 2018 Feb 14, 2019	BUY	$13.99 - $20.35 $2.58 Million - $3.75 Million	184,139 New	184,139 $2.78 Million

Others Institutions Holding HQL

# of Institutions

Shares Held

8.52M

Call Options Held

Put Options Held

Saba Capital Management, L.P. New York, NY

2.46M
Shares

$32.8 Million
0.58% of portfolio
Morgan Stanley New York, NY

484K
Shares

$6.45 Million
0.0% of portfolio
1607 Capital Partners, LLC Richmond, VA

481K
Shares

$6.41 Million
0.54% of portfolio
Allspring Global Investments Holdings, LLC

431K
Shares

$5.75 Million
0.01% of portfolio
Aqr Arbitrage LLC Greenwich, CT

387K
Shares

$5.16 Million
0.32% of portfolio

View Full List

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

More about HQL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account